Insider Trading Alert - CME, COL, BCR, LNKD And OVTI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 17, 2013, 129 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $69.90 to $563,062,500.00.

Highlighted Stocks Traded by Insiders:

CME Group (CME) - FREE Research Report

Clegg Jackie M who is Director at CME Group sold 2,000 shares at $81.10 on Dec. 17, 2013. Following this transaction, the Director owned 7,155 shares meaning that the stake was reduced by 21.85% with the 2,000-share transaction.

The shares most recently traded at $83.16, up $2.06, or 2.48% since the insider transaction. Historical insider transactions for CME Group go as follows:

  • 4-Week # shares sold: 2,516
  • 12-Week # shares bought: 350
  • 12-Week # shares sold: 5,748
  • 24-Week # shares bought: 350
  • 24-Week # shares sold: 12,085

The average volume for CME Group has been 1.5 million shares per day over the past 30 days. CME Group has a market cap of $27.6 billion and is part of the financial sector and financial services industry. Shares are up 63.59% year-to-date as of the close of trading on Tuesday.

CME Group Inc. operates the CME, CBOT, NYMEX COMEX, and KCBT futures exchanges worldwide. It operates CBOT exchange, a marketplace for trading agricultural and the U.S. The stock currently has a dividend yield of 2.19%. The company has a P/E ratio of 28.9. Currently there are 7 analysts that rate CME Group a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CME - FREE

TheStreet Quant Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full CME Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Novice Trade: CBOE

With $150 Trillion at Stake, Tainted Libor Benchmark Won't Die Quickly

Has Chicago Mercantile Exchange Reached a Bottom?

Bullish and Bearish Reversals for This Week